BIORESTORATIVE THERAPIES, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $166.40 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-27.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2023-03-27
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-09-30 was $166.40K.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2018-12-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2018-09-30 was $47.88K.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2018-06-30 was $0.00.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2021 was $166.40K, a 96.72% decline from fiscal 2020.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2020 was $5.08M.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2018 was $69.39K, a 478.72% increase from fiscal 2017.
- BIORESTORATIVE THERAPIES, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2017 was $11.99K, a 94.82% decline from fiscal 2016.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2021-12-31 | $166.40K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $166.40K 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $5.08M 10-K · filed 2021-04-30 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $47.88K derived: sum of 2 quarters · filed 2021-03-18 | $47.88K derived: sum of 3 quarters · filed 2021-03-18 | $69.39K 10-K · filed 2021-03-18 |
| 2018-09-30 | $47.88K 10-Q · filed 2019-11-13 | $47.88K derived: sum of 2 quarters · filed 2019-11-13 | $69.39K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $21.52K 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | $21.52K 10-Q · filed 2019-08-14 | |||
| 2017-12-31 | $11.99K 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $231.71K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |